1. Home
  2. FORA vs BOLD Comparison

FORA vs BOLD Comparison

Compare FORA & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FORA
  • BOLD
  • Stock Information
  • Founded
  • FORA 2014
  • BOLD 2018
  • Country
  • FORA United States
  • BOLD United States
  • Employees
  • FORA N/A
  • BOLD N/A
  • Industry
  • FORA Computer Software: Prepackaged Software
  • BOLD
  • Sector
  • FORA Technology
  • BOLD
  • Exchange
  • FORA Nasdaq
  • BOLD Nasdaq
  • Market Cap
  • FORA 69.4M
  • BOLD 24.4M
  • IPO Year
  • FORA N/A
  • BOLD 2024
  • Fundamental
  • Price
  • FORA $2.31
  • BOLD $1.14
  • Analyst Decision
  • FORA Strong Buy
  • BOLD Buy
  • Analyst Count
  • FORA 1
  • BOLD 4
  • Target Price
  • FORA $5.00
  • BOLD $4.00
  • AVG Volume (30 Days)
  • FORA 76.2K
  • BOLD 66.0K
  • Earning Date
  • FORA 11-12-2025
  • BOLD 11-06-2025
  • Dividend Yield
  • FORA N/A
  • BOLD N/A
  • EPS Growth
  • FORA N/A
  • BOLD N/A
  • EPS
  • FORA N/A
  • BOLD N/A
  • Revenue
  • FORA $25,031,040.00
  • BOLD N/A
  • Revenue This Year
  • FORA $47.82
  • BOLD N/A
  • Revenue Next Year
  • FORA $10.11
  • BOLD N/A
  • P/E Ratio
  • FORA N/A
  • BOLD N/A
  • Revenue Growth
  • FORA 18.59
  • BOLD N/A
  • 52 Week Low
  • FORA $1.64
  • BOLD $1.00
  • 52 Week High
  • FORA $4.03
  • BOLD $4.72
  • Technical
  • Relative Strength Index (RSI)
  • FORA 62.63
  • BOLD 47.21
  • Support Level
  • FORA $2.20
  • BOLD $1.13
  • Resistance Level
  • FORA $2.39
  • BOLD $1.19
  • Average True Range (ATR)
  • FORA 0.13
  • BOLD 0.04
  • MACD
  • FORA 0.02
  • BOLD 0.00
  • Stochastic Oscillator
  • FORA 83.33
  • BOLD 44.44

About FORA Forian Inc.

Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

Share on Social Networks: